76
Participants
Start Date
September 30, 1999
Primary Completion Date
January 31, 2016
Study Completion Date
October 31, 2018
Autologous Hematopoietic Stem Cell Transplantation
Undergo autologous transplantation
Autologous-Allogeneic Tandem Hematopoietic Stem Cell Transplantation
Undergo autologous-allogeneic tandem hematopoietic stem cell transplantation
Carmustine
Given IV
Cyclophosphamide
Given IV
Cyclosporine
Given PO
Cytarabine
Given IV
Etoposide
Given IV
Fludarabine Phosphate
Given IV
Laboratory Biomarker Analysis
Correlative studies
Melphalan
Given IV
Mycophenolate Mofetil
Given PO
Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation
Undergo allogeneic transplantation
Peripheral Blood Stem Cell Transplantation
Undergo allogeneic transplantation
Therapeutic Autologous Lymphocytes
IV donor lymphocyte infusion
Total-Body Irradiation
Undergo radiotherapy
Huntsman Cancer Institute/University of Utah, Salt Lake City
LDS Hospital, Salt Lake City
VA Puget Sound Health Care System, Seattle
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle
Universitaet Leipzig, Leipzig
National Cancer Institute (NCI)
NIH
Fred Hutchinson Cancer Center
OTHER